Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

28.6%

2 terminated/withdrawn out of 7 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

3 recruiting1 with results

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 4

1(20.0%)

Early Phase 1

1(20.0%)

5Total

N/A(3)

Phase 4(1)

Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT04445025Early Phase 1Completed

Comparison Elagolix vs Depot Leuprolide Prior to Frozen Embryo Transfers in Patients With Endometriosis

Role: lead

NCT06633120Not ApplicableRecruiting

In Vitro Maturation of Human Eggs

Role: lead

NCT03717441Recruiting

DNA Analysis of Discarded Media Drops From the Clinical IVF Cycles

Role: lead

NCT04472156Not ApplicableRecruiting

A Prospective Study of a Mosaic Embryo Transfer

Role: lead

NCT03646825Terminated

Effect of Natural Antioxidant Supplement on Sperm DNA Fragmentation

Role: lead

NCT02990949Not ApplicableTerminated

The Impact of the Timing of Trigger on IVF Success

Role: lead

NCT00621179Phase 4Completed

Endometrial Markers and Response of Endometriosis Patients to Prolonged GnRH Agonist Prior to IVF

Role: lead

All 7 trials loaded